The metabolic syndrome

被引:12
作者
Boehm, BO [1 ]
Claudi-Boehm, S [1 ]
机构
[1] Univ Ulm, Dept Internal Med, Div Endocrinol & Diabet, D-89081 Ulm, Germany
关键词
adiponectin; adipokinome; ATP III-criteria; diabetes mellitus; endothelial dysfunction; metabolic syndrome; microalbuminuria;
D O I
10.1080/00365510500236044
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The metabolic syndrome is a multifaceted clinical entity resulting from the interaction of genetic, hormonal, and lifestyle factors. Over the past two decades, the number of people diagnosed with the syndrome has steadily increased and is associated with the global epidemic of obesity and diabetes. The metabolic syndrome is characterized by the clustering of disorders which includes high blood pressure, high (pro)insulin concentrations, excess body weight with central obesity, and an altered lipid profile (dyslipidaemia) that increase the likelihood to develop micro- and macrovascular complications, including coronary heart disease or stroke. Each of these disorders is by itself a risk factor for other diseases including diabetes mellitus. In combination, morbidity and mortality are dramatically increased. Because the defining thresholds for establishing the diagnosis of the metabolic syndrome are controversial, the NCEP: ATP III and the WHO have made specific suggestions. The current definitions of the metabolic syndrome can be used as predictors of vascular complications. Risk assessment and subsequent selection of probands for intervention, such as weight reduction and increased physical activity are recommended for the clinical management of the metabolic syndrome.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 60 条
[21]  
HALLER H, 1979, ENDOKRINOLOGIE, V74, P63
[22]  
Haller H, 1977, Z Gesamte Inn Med, V32, P124
[23]  
HALLER H, 1973, Z GESAMTE INN MED S, V28, P211
[24]   Elevations in markers of liver injury and risk of type 2 diabetes - The insulin resistance atherosclerosis study [J].
Hanley, AJG ;
Williams, K ;
Festa, A ;
Wagenknecht, LE ;
D'Agostino, RB ;
Kempf, J ;
Zinman, B ;
Haffner, SM .
DIABETES, 2004, 53 (10) :2623-2632
[25]   National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study [J].
Hunt, KJ ;
Resendez, RG ;
Williams, K ;
Haffner, SM ;
Stern, MP .
CIRCULATION, 2004, 110 (10) :1251-1257
[26]   Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults [J].
Kim, HJ ;
Kim, HJ ;
Lee, KE ;
Kim, DJ ;
Kim, SK ;
Ahn, CW ;
Lim, SK ;
Kim, KR ;
Lee, HC ;
Huh, KB ;
Cha, BS .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (19) :2169-2175
[27]  
Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
[28]   C-reactive protein modulates risk prediction based on the Framingham score -: Implications for future risk assessment:: Results from a large cohort study in southern Germany [J].
Koenig, W ;
Löwel, H ;
Baumert, J ;
Meisinger, C .
CIRCULATION, 2004, 109 (11) :1349-1353
[29]  
Koenig W, 2003, THROMB HAEMOSTASIS, V89, P601
[30]  
Leonhardt W, 1975, Z Gesamte Inn Med, V30, P52